Detection of HBV, HCV, HIV and HPV viruses using molecular techniques with provision of automated analysers

Summary

The tender concerns the continuous supply of reagents and consumables for molecular detection of HBV, HCV, HIV and HPV, together with the provision of automated analysers for clinical laboratory and pathology services. The contract includes three analysers, associated IT equipment, installation, maintenance, integration and technical support. If the initial capacity is insufficient, one additional analyser must be supplied at no extra cost. The offered system must automate the full molecular workflow, prevent cross-contamination, ensure traceability, support liquid cytology samples and meet specified viral-load and HPV detection requirements. Reagents must be CE-marked for in vitro diagnostic use, and HPV reagents must meet the stated clinical validation, genotype, real-time PCR and shelf-life requirements. Bidders must submit the required eligibility declaration, technical proposal, virtualisation proposal, list of included materials, installation schedule, training plan and evidence supporting the required technical characteristics. The tender deadline is 13 October 2026. Specific financial and experience thresholds are not stated in the provided text and should be checked in the official tender documents.